MITO 32
Randomized phase II randomized trial on Letrozole vs clinician’s choice chemotherapy in heavily pretreated recurrent ovarian, primary peritoneal or fallopian tube cancers
Centro Coordinatore: Fondazione Policlinico Universitario A. Gemelli - IRCCS
Principal Investigator: Claudia Marchetti
Study Coordinator: -
Documentazione disponibile
Ongoing
Tipologia Studio
N/A
Patologie
Ovaio